195 related articles for article (PubMed ID: 36070764)
21. Determination of a Predictive Cleavage Motif for Eluted Major Histocompatibility Complex Class II Ligands.
Paul S; Karosiene E; Dhanda SK; Jurtz V; Edwards L; Nielsen M; Sette A; Peters B
Front Immunol; 2018; 9():1795. PubMed ID: 30127785
[TBL] [Abstract][Full Text] [Related]
22. Malignant glioma cells use MHC class II transactivator (CIITA) promoters III and IV to direct IFN-gamma-inducible CIITA expression and can function as nonprofessional antigen presenting cells in endocytic processing and CD4(+) T-cell activation.
Soos JM; Krieger JI; Stüve O; King CL; Patarroyo JC; Aldape K; Wosik K; Slavin AJ; Nelson PA; Antel JP; Zamvil SS
Glia; 2001 Dec; 36(3):391-405. PubMed ID: 11746775
[TBL] [Abstract][Full Text] [Related]
23. Induction of MHC class I presentation of exogenous antigen by dendritic cells is controlled by CD4+ T cells engaging class II molecules in cholesterol-rich domains.
Machy P; Serre K; Baillet M; Leserman L
J Immunol; 2002 Feb; 168(3):1172-80. PubMed ID: 11801652
[TBL] [Abstract][Full Text] [Related]
24. Autophagy protein ATG5 regulates CD36 expression and anti-tumor MHC class II antigen presentation in dendritic cells.
Oh DS; Lee HK
Autophagy; 2019 Dec; 15(12):2091-2106. PubMed ID: 30900506
[TBL] [Abstract][Full Text] [Related]
25. Infection of mouse bone marrow-derived dendritic cells with recombinant adenovirus vectors leads to presentation of encoded antigen by both MHC class I and class II molecules-potential benefits in vaccine design.
Herrera OB; Brett S; Lechler RI
Vaccine; 2002 Dec; 21(3-4):231-42. PubMed ID: 12450698
[TBL] [Abstract][Full Text] [Related]
26. Presentation of a self-peptide for in vivo tolerance induction of CD4+ T cells is governed by a processing factor that maps to the class II region of the major histocompatibility complex locus.
Fedoseyeva EV; Tam RC; Orr PL; Garovoy MR; Benichou G
J Exp Med; 1995 Nov; 182(5):1481-91. PubMed ID: 7595218
[TBL] [Abstract][Full Text] [Related]
27. Class I and class II major histocompatibility complex antigens expression on human hepatocytes and hepatoma cells: an approach with high sensitivity and specificity.
Chiu JH; Lui WY; Chang HM; Loong CC; Wu LH; Kao HL; Wu CW
Cytometry; 1997 Dec; 30(6):317-23. PubMed ID: 9440824
[TBL] [Abstract][Full Text] [Related]
28. Autophagy proteins influence endocytosis for MHC restricted antigen presentation.
Münz C
Semin Cancer Biol; 2020 Nov; 66():110-115. PubMed ID: 30928540
[TBL] [Abstract][Full Text] [Related]
29. CD9 Regulates Major Histocompatibility Complex Class II Trafficking in Monocyte-Derived Dendritic Cells.
Rocha-Perugini V; Martínez Del Hoyo G; González-Granado JM; Ramírez-Huesca M; Zorita V; Rubinstein E; Boucheix C; Sánchez-Madrid F
Mol Cell Biol; 2017 Aug; 37(15):. PubMed ID: 28533221
[TBL] [Abstract][Full Text] [Related]
30. Lymphocyte-mediated activation of cultured endothelial cells (EC). CD4+ T cells inhibit EC class II MHC expression despite secreting IFN-gamma and increasing EC class I MHC and intercellular adhesion molecule-1 expression.
Doukas J; Pober JS
J Immunol; 1990 Aug; 145(4):1088-98. PubMed ID: 1974272
[TBL] [Abstract][Full Text] [Related]
31. Transport of peptide-MHC class II complexes in developing dendritic cells.
Turley SJ; Inaba K; Garrett WS; Ebersold M; Unternaehrer J; Steinman RM; Mellman I
Science; 2000 Apr; 288(5465):522-7. PubMed ID: 10775112
[TBL] [Abstract][Full Text] [Related]
32. Heparan sulfates targeting increases MHC class I- and MHC class II-restricted antigen presentation and CD8(+) T-cell response.
Knittel D; Gadzinski A; Hua S; Denizeau J; Savatier A; de la Rochère P; Boulain JC; Amigorena S; Piaggio E; Sedlik C; Léonetti M
Vaccine; 2016 Jun; 34(27):3093-3101. PubMed ID: 27154391
[TBL] [Abstract][Full Text] [Related]
33. MHC presentation via autophagy and how viruses escape from it.
Gannage M; Münz C
Semin Immunopathol; 2010 Dec; 32(4):373-81. PubMed ID: 20857294
[TBL] [Abstract][Full Text] [Related]
34. Human hepatoma cells expressing MHC antigens display accessory cell function: dependence on LFA-1/ICAM-1 interaction.
Paroli M; Carloni G; Franco A; De Petrillo G; Alfani E; Perrone A; Barnaba V
Immunology; 1994 Jun; 82(2):215-21. PubMed ID: 7927492
[TBL] [Abstract][Full Text] [Related]
35. Antigen loading of MHC class I molecules in the endocytic tract.
Kleijmeer MJ; Escola JM; UytdeHaag FG; Jakobson E; Griffith JM; Osterhaus AD; Stoorvogel W; Melief CJ; Rabouille C; Geuze HJ
Traffic; 2001 Feb; 2(2):124-37. PubMed ID: 11247303
[TBL] [Abstract][Full Text] [Related]
36. Processing and major histocompatibility complex class II presentation of Legionella pneumophila antigens by infected macrophages.
Neild A; Murata T; Roy CR
Infect Immun; 2005 Apr; 73(4):2336-43. PubMed ID: 15784579
[TBL] [Abstract][Full Text] [Related]
37. Curative antitumor immune response is optimal with tumor irradiation followed by genetic induction of major histocompatibility complex class I and class II molecules and suppression of Ii protein.
Wang Y; Xu M; Che M; Von Hofe E; Abbas A; Kallinteris NL; Lu X; Liss ZJ; Forman JD; Hillman GG
Hum Gene Ther; 2005 Feb; 16(2):187-99. PubMed ID: 15761259
[TBL] [Abstract][Full Text] [Related]
38. LAMP-2-deficient human B cells exhibit altered MHC class II presentation of exogenous antigens.
Crotzer VL; Glosson N; Zhou D; Nishino I; Blum JS
Immunology; 2010 Nov; 131(3):318-30. PubMed ID: 20518820
[TBL] [Abstract][Full Text] [Related]
39. Molecular cloning and characterization of MHC class I- and II-restricted tumor antigens recognized by T cells.
Wang RF
Curr Protoc Immunol; 2009 Feb; Chapter 20():20.10.1-20.10.29. PubMed ID: 19235768
[TBL] [Abstract][Full Text] [Related]
40. MHC class II presentation is controlled by the lysosomal small GTPase, Arl8b.
Michelet X; Garg S; Wolf BJ; Tuli A; Ricciardi-Castagnoli P; Brenner MB
J Immunol; 2015 Mar; 194(5):2079-88. PubMed ID: 25637027
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]